Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement

@inproceedings{Salter2014DemonstrationOE,
  title={Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement},
  author={Sandra M Salter and Richard K S Loh and Frank M. Sanfilippo and Rhonda Marise Clifford},
  booktitle={Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology},
  year={2014}
}
BACKGROUND Successful treatment of anaphylaxis in the community relies on early and correct use of epinephrine autoinjectors. Community pharmacists supply these devices and have a crucial role teaching patients how to use them. Supply of epinephrine autoinjectors in Australia increased 70-fold in the past decade. New EpiPen and Anapen autoinjectors were launched in Australia in 2011 and 2012, with the potential to cause confusion. However there is no information about how pharmacists… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 6 times over the past 90 days. VIEW TWEETS